Discover
HRMY
Harmony Biosciences Holdings, Inc.
36.00
2 x 26.07
2 x 45.61
bid
ask
-
0.41
1.13%
2 @ 04:00 PM
35.75 -0.25 (0.69%)
| Ytd | -3.79% | |
| 1y | 12.39% |
35.46
day range
36.64
25.52
52 week range
40.87
| Open | 36.50 | Prev Close | 36.41 | Low | 35.46 | High | 36.64 | Mkt Cap | 2.08B |
| Vol | 736.68K | Avg Vol | 834.25K | EPS | 2.48 | P/E | 14.52 | Forward P/E | 6.05 |
| Beta | 0.97 | Short Ratio | 5.83 | Inst. Own | 103.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 32.35 | 200-d Avg | 32.30 | 1yr Est | 44.36 |
HRMY News
benzinga.com
Deutsche Bank Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $36
Deutsche Bank analyst David Hoang maintains Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Hold a
zacks.com
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?
Harmony Biosciences trades at discounted valuations, but investors are weighing Wakix dependence, re
zacks.com
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline
Harmony Biosciences is leveraging Wakix growth to expand its neuroscience pipeline, while advancing
zacks.com
HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase
Harmony Biosciences is broadening beyond Wakix with pitolisant programs, orexin research and rare ep